Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Charron

Showing results (21-30 of 310) with videos related to

Pageof 31
Sort By:
Health Physics|September 1, 1985
The distribution of a pulsed very low frequency electric field around video display terminalsK Marha, D Charron
Bulletin Du Cancer|September 1, 1993
[Demonstration of transcriptional regulation of protein kinase C by class II anti-HLA antibodies in human CA cells of the lymphoblastoid line]C Brick-Ghannam, D Charron
The Diabetes Educator|January 1, 1984
Care of the infant with type I diabetes mellitusD Charron-Prochownik, S Schwartz
Nursing Quebec|May 1, 1993
[The baccalaureate in nursing sciences at the University of Quebec and Abitibi-Temiscamingue]M Bolduc-Bourdouxhe, D Charron
The Diabetes Educator|January 1, 1985
A course for babysitters of children with IDDML Albright, D Charron-Prochwnik
Tissue Antigens|July 25, 2015
Allogenic benefit in stem cell therapy: cardiac repair and regenerationR Al-Daccak, D Charron
Revue Du Rhumatisme (English Ed.)|November 24, 1999
The genetics of spondylarthropathiesA Toubert, R Tamouza, D Charron
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Double-blind, placebo-controlled lithium treatment in chemotherapy induced aplasia for AML: reduced antibiotic requirementS Collado, D Charron, L Degos
Cellular Immunology|July 15, 1982
Role of HLA-DR antigens in antibody production: monoclonal anti-HLA-DR antibodies differ in their ability to directly inhibit B-cell responseA Vazquez, D Charron, P Galanaud
Diabetes Care|October 1, 1995
Well-child care and IDDM: whose responsibility?S L Wilson, D Charron-Prochownik
Pageof 31

Showing results (21-30 of 310) with videos related to

Sort By:
Pageof 31
Health Physics|September 1, 1985
The distribution of a pulsed very low frequency electric field around video display terminalsK Marha, D Charron
Bulletin Du Cancer|September 1, 1993
[Demonstration of transcriptional regulation of protein kinase C by class II anti-HLA antibodies in human CA cells of the lymphoblastoid line]C Brick-Ghannam, D Charron
The Diabetes Educator|January 1, 1984
Care of the infant with type I diabetes mellitusD Charron-Prochownik, S Schwartz
Nursing Quebec|May 1, 1993
[The baccalaureate in nursing sciences at the University of Quebec and Abitibi-Temiscamingue]M Bolduc-Bourdouxhe, D Charron
The Diabetes Educator|January 1, 1985
A course for babysitters of children with IDDML Albright, D Charron-Prochwnik
Tissue Antigens|July 25, 2015
Allogenic benefit in stem cell therapy: cardiac repair and regenerationR Al-Daccak, D Charron
Revue Du Rhumatisme (English Ed.)|November 24, 1999
The genetics of spondylarthropathiesA Toubert, R Tamouza, D Charron
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
Double-blind, placebo-controlled lithium treatment in chemotherapy induced aplasia for AML: reduced antibiotic requirementS Collado, D Charron, L Degos
Cellular Immunology|July 15, 1982
Role of HLA-DR antigens in antibody production: monoclonal anti-HLA-DR antibodies differ in their ability to directly inhibit B-cell responseA Vazquez, D Charron, P Galanaud
Diabetes Care|October 1, 1995
Well-child care and IDDM: whose responsibility?S L Wilson, D Charron-Prochownik
Pageof 31